{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:26:02Z","timestamp":1791134762681,"version":"4.1.0"},"reference-count":12,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"6","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2009]]},"DOI":"10.2133\/dmpk.24.553","type":"journal-article","created":{"date-parts":[[2010,1,4]],"date-time":"2010-01-04T05:54:16Z","timestamp":1262584456000},"page":"553-556","source":"Crossref","is-referenced-by-count":36,"title":["Ethnic Differences of two Non-synonymous Single Nucleotide Polymorphisms in CDA Gene"],"prefix":"10.2133","volume":"24","author":[{"given":"Emiko","family":"Sugiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Seop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Ryang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tohkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiro","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Kamatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahoko","family":"Kaniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Gook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.24.553_bb0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.tpj.6500320","article-title":"Genetic factors influencing pyrimidine-antagonist chemotherapy","volume":"5","author":"Maring","year":"2005","journal-title":"Pharmacogenomics J."},{"key":"10.2133\/dmpk.24.553_bb0010","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1158\/1078-0432.CCR-05-1969","article-title":"Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics","volume":"12","author":"Gilbert","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.2133\/dmpk.24.553_bb0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/15257770802145447","article-title":"Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples","volume":"27","author":"Giovannetti","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.2133\/dmpk.24.553_bb0020","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1158\/1078-0432.CCR-07-1364","article-title":"Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine\/cisplatin-treated advanced non-small cell lung cancer patients","volume":"14","author":"Tibaldi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.2133\/dmpk.24.553_bb0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00008571-200301000-00005","article-title":"A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity","volume":"13","author":"Yue","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.2133\/dmpk.24.553_bb0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.2006.06.7405","article-title":"Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism","volume":"25","author":"Sugiyama","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.2133\/dmpk.24.553_bb0035","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1158\/1078-0432.CCR-04-1497","article-title":"Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin","volume":"11","author":"Yonemori","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.2133\/dmpk.24.553_bb0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/dmd.104.001800","article-title":"Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C>T (P229L) found in an African-American","volume":"33","author":"Kaniwa","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.24.553_bb0045","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1373\/49.7.1182","article-title":"Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing","volume":"49","author":"Saeki","year":"2003","journal-title":"Clin. Chem"},{"issue":"699\u2013702","key":"10.2133\/dmpk.24.553_bb0050","article-title":"Single-nucleotide polymorphisms of the cytidine deaminase gene in childhood with acute leukemia and normal Chinese children","volume":"24","author":"Yue","year":"2007","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"10.2133\/dmpk.24.553_bb0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.tpj.6500259","article-title":"Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway","volume":"4","author":"Fukunaga","year":"2004","journal-title":"Pharmacogenomics J."},{"key":"10.2133\/dmpk.24.553_bb0060","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjc.6604971","article-title":"Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients","volume":"100","author":"Ueno","year":"2009","journal-title":"Br. J. Cancer"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715301488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715301488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T22:08:41Z","timestamp":1558735721000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715301488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"alternative-id":["S1347436715301488"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.24.553","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}